|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of CRISPR Therapeutics (NASDAQ: CRSP) through any online brokerage.
There are no as such competitors for CRISPR Therapeutics.
The latest price target for CRISPR Therapeutics (NASDAQ: CRSP) was reported by Citigroup on June 14, 2021. The analyst firm set a price target for 132.00 expecting CRSP to rise to within 12 months (a possible 3.26% upside). 18 analyst firms have reported ratings in the last year.
The stock price for CRISPR Therapeutics (NASDAQ: CRSP) is $127.83 last updated Fri Jun 18 2021 20:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for CRISPR Therapeutics.
There is no upcoming split for CRISPR Therapeutics.
CRISPR Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.